Last reviewed · How we verify
Phase 4 Study Comparing the Efficacy of Etoricoxib Versus Gabapentin as Part of a Multimodal Analgesic Regimen for Ambulatory Knee Arthroscopy
To determine that when administered as part of a multimodal analgesic regimen, use of the new COX-2 antagonist etoricoxib (120 mg/day, per os) is more effective in improving postoperative pain management after knee arthroscopy than gabapentin (1.2 g/day, per os).
Details
| Lead sponsor | Meir Medical Center |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 75 |
| Start date | 2006-06 |
| Completion | 2007-05 |
Conditions
- Knee Arthroscopy
Interventions
- Gabapentin, Etoricoxib, Sugar pill
Primary outcomes
- 1)Pain intensity (as assessed using a 100 visual analog scale) 2)Incidence of dipyrone usage — 96 hours post-operation
Countries
Israel